In the realm of biological molecules, RNA often takes a backseat to its more renowned counterpart, DNA. While DNA is recognized for its pivotal role in providing genetic instructions for protein synthesis, recent studies have shed light on the critical involvement of RNA-binding proteins in regulating RNA’s messages. Mutations in genes encoding RNA-associated proteins have been linked to various diseases, necessitating a deeper understanding of their functions within cells.
Researchers at Fred Hutch Cancer Center have introduced a novel screening technique known as ReLiC, as detailed in Nature Methods, to address the challenge of unraveling the roles of RNA-associated proteins. Unlike conventional methods that target individual genes, ReLiC employs CRISPR-Cas9 technology to simultaneously test multiple genes in a cell population, enabling the assessment of how these gene deletions impact intricate RNA processes on a larger scale.
The complex journey of RNA within a cell involves transcription, translation, and degradation processes, all of which are intricately influenced by RNA-associated proteins. Messenger RNA acts as an intermediary, ferrying genetic information from DNA to ribosomes, where proteins are synthesized. The action of RNA-associated proteins spans from the initiation of messenger RNA production to its translation into proteins, and ultimately to its degradation upon completion of its function.
The development of ReLiC by the Subramaniam Lab at Fred Hutch has revolutionized the study of RNA regulation by enabling the systematic evaluation of thousands of genes encoding RNA-associated proteins simultaneously. By leveraging CRISPR technology and barcoded RNA sequences, researchers can monitor the impact of gene deletions on various RNA processes that were previously challenging to assess. The method has unveiled vital insights into the intricate networks of molecular pathways and protein interactions involved in RNA processing.
Through ReLiC experiments, researchers have identified key genes essential for messenger RNA translation and uncovered unexpected roles of certain genes in protein synthesis regulation. The technique has also shed light on the molecular pathways influencing cellular responses to specific drugs, offering new perspectives on drug efficacy in diseases like chronic myeloid leukemia. By comprehensively examining the functions of RNA-associated proteins, ReLiC has provided a holistic view of how RNA orchestrates protein production in cells.
Key Takeaways:
– ReLiC, a groundbreaking screening method, allows for the simultaneous evaluation of thousands of genes encoding RNA-associated proteins using CRISPR technology.
– The technique has revealed intricate molecular pathways and protein interactions involved in RNA regulation, offering new insights into cellular processes.
– By targeting multiple genes at once, researchers can now explore how RNA influences protein synthesis and responses to therapeutic drugs in various diseases.
– ReLiC has transformed the study of RNA processes, enabling researchers to address complex questions about cellular functions in a comprehensive manner.
Read more on fredhutch.org